352 related articles for article (PubMed ID: 11803237)
1. Influence of the severity of cognitive impairment on the effect of the Gnkgo biloba extract EGb 761 in Alzheimer's disease.
Le Bars PL; Velasco FM; Ferguson JM; Dessain EC; Kieser M; Hoerr R
Neuropsychobiology; 2002; 45(1):19-26. PubMed ID: 11803237
[TBL] [Abstract][Full Text] [Related]
2. Response patterns of EGb 761 in Alzheimer's disease: influence of neuropsychological profiles.
Le Bars PL
Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S50-5. PubMed ID: 13130389
[TBL] [Abstract][Full Text] [Related]
3. A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia.
Le Bars PL; Kieser M; Itil KZ
Dement Geriatr Cogn Disord; 2000; 11(4):230-7. PubMed ID: 10867450
[TBL] [Abstract][Full Text] [Related]
4. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF
JAMA; 1997 Oct 22-29; 278(16):1327-32. PubMed ID: 9343463
[TBL] [Abstract][Full Text] [Related]
5. Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial.
Kanowski S; Hoerr R
Pharmacopsychiatry; 2003 Nov; 36(6):297-303. PubMed ID: 14663654
[TBL] [Abstract][Full Text] [Related]
6. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
De Jesus Moreno Moreno M
Clin Ther; 2003 Jan; 25(1):178-93. PubMed ID: 12637119
[TBL] [Abstract][Full Text] [Related]
7. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study.
Mazza M; Capuano A; Bria P; Mazza S
Eur J Neurol; 2006 Sep; 13(9):981-5. PubMed ID: 16930364
[TBL] [Abstract][Full Text] [Related]
8. [Delay in progression of dependency and need of care of dementia patients treated with Ginkgo special extract EGb 761].
Haan J; Hörr R
Wien Med Wochenschr; 2004 Nov; 154(21-22):511-4. PubMed ID: 15638069
[TBL] [Abstract][Full Text] [Related]
9. The Alzheimer's Disease Assessment Scale: patterns and predictors of baseline cognitive performance in multicenter Alzheimer's disease trials.
Doraiswamy PM; Bieber F; Kaiser L; Krishnan KR; Reuning-Scherer J; Gulanski B
Neurology; 1997 Jun; 48(6):1511-7. PubMed ID: 9191757
[TBL] [Abstract][Full Text] [Related]
10. Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial.
Farlow M; Potkin S; Koumaras B; Veach J; Mirski D
Arch Neurol; 2003 Jun; 60(6):843-8. PubMed ID: 12810489
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type.
Schneider LS; DeKosky ST; Farlow MR; Tariot PN; Hoerr R; Kieser M
Curr Alzheimer Res; 2005 Dec; 2(5):541-51. PubMed ID: 16375657
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N;
Int J Geriatr Psychiatry; 2014 Oct; 29(10):1087-95. PubMed ID: 24633934
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings.
Mix JA; Crews WD
Hum Psychopharmacol; 2002 Aug; 17(6):267-77. PubMed ID: 12404671
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O;
Int J Geriatr Psychiatry; 2011 Nov; 26(11):1186-94. PubMed ID: 21140383
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: new results of a randomized clinical trial.
van Dongen MC; van Rossum E; Kessels AG; Sielhorst HJ; Knipschild PG
J Am Geriatr Soc; 2000 Oct; 48(10):1183-94. PubMed ID: 11037003
[TBL] [Abstract][Full Text] [Related]
16. Cyclandelate in the treatment of patients with mild to moderate primary degenerative dementia of the Alzheimer type or vascular dementia: experience from a placebo controlled multi-center study.
Weyer G; Eul A; Milde K; Wierich W; Herrmann WM
Pharmacopsychiatry; 2000 May; 33(3):89-97. PubMed ID: 10855459
[TBL] [Abstract][Full Text] [Related]
17. Effects of memantine on cognition in patients with moderate to severe Alzheimer's disease: post-hoc analyses of ADAS-cog and SIB total and single-item scores from six randomized, double-blind, placebo-controlled studies.
Mecocci P; Bladström A; Stender K
Int J Geriatr Psychiatry; 2009 May; 24(5):532-8. PubMed ID: 19274640
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type.
Maurer K; Ihl R; Dierks T; Frölich L
J Psychiatr Res; 1997; 31(6):645-55. PubMed ID: 9447569
[TBL] [Abstract][Full Text] [Related]
19. Treatment effects of Ginkgo biloba extract EGb 761® on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of randomized controlled trials.
Savaskan E; Mueller H; Hoerr R; von Gunten A; Gauthier S
Int Psychogeriatr; 2018 Mar; 30(3):285-293. PubMed ID: 28931444
[TBL] [Abstract][Full Text] [Related]
20. Ginkgo biloba special extract in dementia with neuropsychiatric features. A randomised, placebo-controlled, double-blind clinical trial.
Napryeyenko O; Borzenko I;
Arzneimittelforschung; 2007; 57(1):4-11. PubMed ID: 17341003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]